CRL vs IDN · rev $2.00B vs P/E 35, rev $11.5M
Charles River Laboratories (CRL) versus Intellicheck Mobilisa Inc (IDN) — a side-by-side from cached financials, not a winner call.
Charles River Laboratories (CRL) is a diagnostics & research company listed on US.
Intellicheck Mobilisa Inc (IDN) is a software - application company listed on NASDAQ.
Latest reported CRL revenue for 2026-06-27 was $2.00B. Net income was -$16.3M. CRL currently screens at market cap $7.78B.
Latest reported IDN revenue for 2026-06-30 was $11.5M. Net income was $1.3M. IDN currently screens at market cap $83.8M and trailing P/E 34.5.
CRL currently screens at market cap $7.78B. IDN currently screens at market cap $83.8M and trailing P/E 34.5.
Not investment advice. Open the CRL and IDN stock pages for the full models.
Not investment advice.